ArticleCancer medicine2026

Multi-Omics Analysis of TYMS as a Prognostic Biomarker and Therapeutic Target for Lung Adenocarcinoma.

Hansen Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.